Cytotoxic effects of treosulfan and busulfan against leukemic cells of pediatric patients
Treosulfan is an alkylating agent that is structurally related to busulfan. It is used in the treatment of ovarian carcinoma and currently considered in clinical trials as a conditioning agent prior to autologous […]
Read More →